Miller GP - Search Results

1

Novel isomeric metabolite profiles correlate with warfarin metabolism phenotype during maintenance dosing in a pilot study of 29 patients.

Pouncey DL, Hartman JH, Moore PC, Dillinger DJ, Dickerson KW, Sappington DR, Smith ES 3rd, Boysen G, Miller GP. Pouncey DL, et al. Among authors: miller gp. Blood Coagul Fibrinolysis. 2018 Nov;29(7):602-612. doi: 10.1097/MBC.0000000000000752. Blood Coagul Fibrinolysis. 2018. PMID: 30334816

2

Assessing cytochrome P450 and UDP-glucuronosyltransferase contributions to warfarin metabolism in humans.

Miller GP, Jones DR, Sullivan SZ, Mazur A, Owen SN, Mitchell NC, Radominska-Pandya A, Moran JH. Miller GP, et al. Chem Res Toxicol. 2009 Jul;22(7):1239-45. doi: 10.1021/tx900031z. Chem Res Toxicol. 2009. PMID: 19408964 Free PMC article.

3

Warfarin and UDP-glucuronosyltransferases: writing a new chapter of metabolism.

Jones DR, Moran JH, Miller GP. Jones DR, et al. Among authors: miller gp. Drug Metab Rev. 2010 Feb;42(1):55-61. doi: 10.3109/03602530903209395. Drug Metab Rev. 2010. PMID: 19788348

4

Hydroxywarfarin metabolites potently inhibit CYP2C9 metabolism of S-warfarin.

Jones DR, Kim SY, Guderyon M, Yun CH, Moran JH, Miller GP. Jones DR, et al. Among authors: miller gp. Chem Res Toxicol. 2010 May 17;23(5):939-45. doi: 10.1021/tx1000283. Chem Res Toxicol. 2010. PMID: 20429590 Free PMC article.

5

Contribution of three CYP3A isoforms to metabolism of R- and S-warfarin.

Jones DR, Kim SY, Boysen G, Yun CH, Miller GP. Jones DR, et al. Among authors: miller gp. Drug Metab Lett. 2010 Dec;4(4):213-9. doi: 10.2174/187231210792928242. Drug Metab Lett. 2010. PMID: 20615193

6

Warfarin therapy: how the less interesting half just got interesting.

Miller GP. Miller GP. J Thromb Haemost. 2010 Dec;8(12):2705-7. doi: 10.1111/j.1538-7836.2010.04097.x. J Thromb Haemost. 2010. PMID: 21138521 Free article. No abstract available.

7

Novel multi-mode ultra performance liquid chromatography-tandem mass spectrometry assay for profiling enantiomeric hydroxywarfarins and warfarin in human plasma.

Jones DR, Boysen G, Miller GP. Jones DR, et al. Among authors: miller gp. J Chromatogr B Analyt Technol Biomed Life Sci. 2011 May 1;879(15-16):1056-62. doi: 10.1016/j.jchromb.2011.03.022. Epub 2011 Mar 21. J Chromatogr B Analyt Technol Biomed Life Sci. 2011. PMID: 21470921

8

Assays and applications in warfarin metabolism: what we know, how we know it and what we need to know.

Jones DR, Miller GP. Jones DR, et al. Among authors: miller gp. Expert Opin Drug Metab Toxicol. 2011 Jul;7(7):857-74. doi: 10.1517/17425255.2011.576247. Epub 2011 Apr 12. Expert Opin Drug Metab Toxicol. 2011. PMID: 21480820 Review.

9

CYP2E1 metabolism of styrene involves allostery.

Hartman JH, Boysen G, Miller GP. Hartman JH, et al. Among authors: miller gp. Drug Metab Dispos. 2012 Oct;40(10):1976-83. doi: 10.1124/dmd.112.046698. Epub 2012 Jul 17. Drug Metab Dispos. 2012. PMID: 22807108 Free PMC article.

10

Cooperative effects for CYP2E1 differ between styrene and its metabolites.

Hartman JH, Boysen G, Miller GP. Hartman JH, et al. Among authors: miller gp. Xenobiotica. 2013 Sep;43(9):755-64. doi: 10.3109/00498254.2012.760764. Epub 2013 Jan 18. Xenobiotica. 2013. PMID: 23327532 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

144 results

Search Page

Filters